Umeå University's logo

umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Tryptophan metabolism and vitamin B6 status are associated with the risk of developing inflammatory bowel diseases in a prospective study
Umeå University, Faculty of Medicine, Department of Medical Biosciences, Clinical chemistry.
Umeå University, Faculty of Medicine, Department of Medical Biosciences, Clinical chemistry.ORCID iD: 0000-0003-2844-1310
Umeå University, Faculty of Medicine, Department of Radiation Sciences. Umeå University, Faculty of Medicine, Department of Medical Biosciences.ORCID iD: 0000-0001-8690-2117
Umeå University, Faculty of Medicine, Department of Integrative Medical Biology (IMB).
Show others and affiliations
(English)Manuscript (preprint) (Other academic)
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:umu:diva-208113OAI: oai:DiVA.org:umu-208113DiVA, id: diva2:1755815
Available from: 2023-05-09 Created: 2023-05-09 Last updated: 2023-05-09
In thesis
1. Lifestyle, biomarkers and the risk of developing inflammatory bowel disease
Open this publication in new window or tab >>Lifestyle, biomarkers and the risk of developing inflammatory bowel disease
2023 (English)Doctoral thesis, comprehensive summary (Other academic)
Alternative title[sv]
Livsstil, biomarkörer och risken att utveckla inflammatorisk tarmsjukdom
Abstract [en]

Introduction: Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD), is a chronic disease causing inflammation in the gut mucosa. The pathogenesis involves alteration in gut microbiota and in the intestinal barrier due to genetic factors, environmental exposure and dysregulation of the immune response. Several environmental risk factors and risk genes have been identified, but still, the pathogenesis is not fully understood. 

Methods: Included papers are all case-control studies based on previously collected data stored with the biobank in Umeå, Sweden. Cases are individuals that participated in the Northern Sweden Health and Disease Study (NSHDS) at least one year before developing IBD. Information was available for all cases regarding age, time and place for inclusion in NSHDS, height and weight, sex and tobacco use. Part of the cases also had available data from a detailed food-frequency questionnaire. For each available case, controls matched for age, sex and time and place were selected. Analysed factors included tobacco use, with smoking and snuff use analysed separately), cotinine (a metabolite of nicotine), iron status (including ferritin, iron, transferrin and transferrin saturation), B-vitamins and tryptophan metabolites. 

Results: Smoking was associated with an increased risk of developing IBD both based on questionnaire data and using cotinine as a marker for exposure. Snuff use was not associated with risk for developing IBD. A lower ferritin was associated with an increased risk of developing IBD, whereas no association was seen for other iron status analytes. When analysing iron deficiency based on ferritin and CRP, it was shown that iron deficiency was more common among men before onset of IBD, whereas no difference was seen for women. Active vitamin B6 was lower among cases compared to controls, as well as an index indicating functional B6 deficiency. Kynurenic acid and xanthurenic acid, both tryptophan metabolites with immunomodulatory properties, were lower among cases than controls. For CD only, picolinic acid was lower among cases later developing IBD.

Discussion: Smoking increases the risk of developing both UC and CD. Snuff use did not increase the risk for IBD, indicating that tobacco exposure is not the reason for increased IBD risk. Low ferritin indicates an early pathological process affecting iron storage unrelated to inflammation. Changes in vitamin B6 and tryptophan metabolites might indicate early pathological processes possibly related to gut microbiota changes. 

To conclude, this dissertation shows that multiple differences between individuals later developing IBD and controls can be seen years before IBD diagnosis. Some of which give insight to early pathophysiology in IBD.

Place, publisher, year, edition, pages
Umeå: Umeå University, 2023. p. 86
Series
Umeå University medical dissertations, ISSN 0346-6612 ; 2247
Keywords
Inflammatory bowel disease, ulcerative colitis, Crohn's disease, smoking, cotinine, iron deficiency, ferritin, pyridoxal-5-phosphate, kynurenine pathway
National Category
Clinical Medicine
Research subject
Clinical Chemistry; Internal Medicine
Identifiers
urn:nbn:se:umu:diva-208115 (URN)978-91-8070-035-1 (ISBN)978-91-8070-034-4 (ISBN)
Public defence
2023-06-02, Betula, Byggnad 6M, Norrlands universitetssjukhus, Umeå, 13:00 (Swedish)
Opponent
Supervisors
Available from: 2023-05-12 Created: 2023-05-09 Last updated: 2023-05-10Bibliographically approved

Open Access in DiVA

No full text in DiVA

Authority records

Widbom, LovisaEkblom, KimStefansson, KristinaSchneede, Jörn

Search in DiVA

By author/editor
Widbom, LovisaEkblom, KimStefansson, KristinaSchneede, Jörn
By organisation
Clinical chemistryDepartment of Radiation SciencesDepartment of Medical BiosciencesDepartment of Integrative Medical Biology (IMB)
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 204 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf